Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.
3.

Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy.

Hemminki A, Mecklin JP, Järvinen H, Aaltonen LA, Joensuu H.

Gastroenterology. 2000 Oct;119(4):921-8.

PMID:
11040179
4.

Prognostic and predictive relevance of microsatellite instability in colorectal cancer.

Storojeva I, Boulay JL, Heinimann K, Ballabeni P, Terracciano L, Laffer U, Mild G, Herrmann R, Rochlitz C.

Oncol Rep. 2005 Jul;14(1):241-9.

PMID:
15944796
5.

Chemosensitivity and survival in gastric cancer patients with microsatellite instability.

Oki E, Kakeji Y, Zhao Y, Yoshida R, Ando K, Masuda T, Ohgaki K, Morita M, Maehara Y.

Ann Surg Oncol. 2009 Sep;16(9):2510-5. doi: 10.1245/s10434-009-0580-8. Epub 2009 Jun 30.

PMID:
19565284
6.

P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma.

Elsaleh H, Powell B, McCaul K, Grieu F, Grant R, Joseph D, Iacopetta B.

Clin Cancer Res. 2001 May;7(5):1343-9.

7.

Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.

Westra JL, Schaapveld M, Hollema H, de Boer JP, Kraak MM, de Jong D, ter Elst A, Mulder NH, Buys CH, Hofstra RM, Plukker JT.

J Clin Oncol. 2005 Aug 20;23(24):5635-43.

PMID:
16110022
8.

Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis.

Des Guetz G, Schischmanoff O, Nicolas P, Perret GY, Morere JF, Uzzan B.

Eur J Cancer. 2009 Jul;45(10):1890-6. doi: 10.1016/j.ejca.2009.04.018. Epub 2009 May 6. Review.

PMID:
19427194
9.

Prognostic significance of interaction between somatic APC mutations and 5-fluorouracil adjuvant chemotherapy in Taiwanese colorectal cancer subjects.

Chen SP, Wu CC, Lin SZ, Kang JC, Su CC, Chen YL, Lin PC, Chiu SC, Pang CY, Harn HJ.

Am J Clin Oncol. 2009 Apr;32(2):122-6. doi: 10.1097/COC.0b013e318181f959.

PMID:
19307944
10.

Microsatellite instability and colorectal cancer prognosis.

Benatti P, Gafà R, Barana D, Marino M, Scarselli A, Pedroni M, Maestri I, Guerzoni L, Roncucci L, Menigatti M, Roncari B, Maffei S, Rossi G, Ponti G, Santini A, Losi L, Di Gregorio C, Oliani C, Ponz de Leon M, Lanza G.

Clin Cancer Res. 2005 Dec 1;11(23):8332-40. Erratum in: Clin Cancer Res. 2006 Jun 15;12(12):3868-9.

11.

Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.

Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, Piñol V, Xicola RM, Bujanda L, Reñé JM, Clofent J, Bessa X, Morillas JD, Nicolás-Pérez D, Payá A, Alenda C; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.

Gut. 2006 Jun;55(6):848-55. Epub 2005 Nov 18.

12.
13.

Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.

Malesci A, Laghi L, Bianchi P, Delconte G, Randolph A, Torri V, Carnaghi C, Doci R, Rosati R, Montorsi M, Roncalli M, Gennari L, Santoro A.

Clin Cancer Res. 2007 Jul 1;13(13):3831-9.

14.

Chemotherapy and survival in colorectal cancer patients with and without microsatellite instability: can MSI be a prognostic marker?

Watanabe T, Kanazawa T, Tada T, Kazama Y, Hata K, Nagawa H.

Gastroenterology. 2004 Aug;127(2):688-9; author reply 689-90. No abstract available.

PMID:
15300610
15.

Systematic review of microsatellite instability and colorectal cancer prognosis.

Popat S, Hubner R, Houlston RS.

J Clin Oncol. 2005 Jan 20;23(3):609-18. Review.

PMID:
15659508
16.

Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle.

Tejpar S, Saridaki Z, Delorenzi M, Bosman F, Roth AD.

J Natl Cancer Inst. 2011 Jun 8;103(11):841-4. doi: 10.1093/jnci/djr170. Epub 2011 May 19. No abstract available.

PMID:
21597023
17.

Microsatellite instability does not predict the efficacy of chemotherapy in metastatic colorectal cancer. A systematic review and meta-analysis.

Des Guetz G, Uzzan B, Nicolas P, Schischmanoff O, Perret GY, Morere JF.

Anticancer Res. 2009 May;29(5):1615-20. Review.

18.

The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status.

Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, Balaguer F, Sempere L, Xicola RM, Bujanda L, Reñé JM, Clofent J, Bessa X, Morillas JD, Nicolás-Pérez D, Pons E, Payá A, Alenda C; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.

Eur J Cancer. 2009 Feb;45(3):365-73. doi: 10.1016/j.ejca.2008.07.016. Epub 2008 Aug 21.

PMID:
18722765
19.

A prospective analysis of microsatellite instability as a molecular marker in colorectal cancer.

Chang EY, Dorsey PB, Johnson N, Lee R, Walts D, Johnson W, Anadiotis G, Kiser K, Frankhouse J.

Am J Surg. 2006 May;191(5):646-51.

PMID:
16647353
20.

Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.

Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C.

Oncology. 2006;70(5):366-77. Epub 2006 Dec 15.

PMID:
17179731

Supplemental Content

Support Center